Skip to main
MMSI
MMSI logo

MMSI Stock Forecast & Price Target

MMSI Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 36%
Buy 50%
Hold 14%
Sell 0%
Strong Sell 0%

Bulls say

Merit Medical Systems Inc. demonstrated strong financial performance, with an operating margin increase of 300 basis points year-over-year, driven by a notable 310 basis point expansion in gross margins. The company's Cardiovascular segment achieved a revenue growth of 7.8%, supported by robust sales in cardiac intervention and a remarkable 28% increase in Delivery Systems revenue, while Endoscopy sales surged 88.1%, reflecting both organic growth and recent acquisitions. Overall, the total revenue rose by 9.4% as reported, indicating positive momentum across its product lines and a favorable macroeconomic backdrop.

Bears say

Merit Medical Systems Inc. faces significant challenges that contribute to a negative outlook on its stock, primarily stemming from disappointing earnings guidance for FY/25, which was below market expectations. The company is projected to experience revenue growth of 5% or lower, largely due to underperformance from recent acquisitions and unsuccessful new product launches, leading to further contraction in operating margins. Additionally, with an estimated dilutive impact of approximately $0.11 on non-GAAP EPS in 2025 and concerns regarding margin performance and free cash flow, the financial stability of the firm appears increasingly precarious.

MMSI has been analyzed by 14 analysts, with a consensus rating of Buy. 36% of analysts recommend a Strong Buy, 50% recommend Buy, 14% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Merit Medical Systems and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Merit Medical Systems (MMSI) Forecast

Analysts have given MMSI a Buy based on their latest research and market trends.

According to 14 analysts, MMSI has a Buy consensus rating as of Aug 3, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $90.21, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $90.21, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Merit Medical Systems (MMSI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.